1 0

    FDA 483 for AstraZeneca Pharmaceuticals LP Inspection Ending Jun 7, 2024 (FEI 3002617771)

    FDA 483 for AstraZeneca Pharmaceuticals LP Inspection Ending Jun 7, 2024 (FEI 3002617771)

    $69.00 USD
    $69.00 USD
    Sale Sold out
    Original Request: To Whom it May Concern: As permitted by the Freedom of Information Act (FOIA), I am hereby requesting the following document: Form FDA 483 AstraZeneca Pharmaceuticals LP Frederick United States of America End Dates of inspection: 07 June 2024 Project Area: Drug Quality Assurance FEI: 3002617771 Investigator(s): Liqun Zhao, Kristen Nickens, PhD, Vidya B Pai, Wayne E Seifert, Christina Farris Classification: VAI
    Tags: Pharma, 483, 2024
    • Status: Pending Fast-Track Request
    • Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity

    NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. IMPORTANT: The FDA FOIA office operations are currently suspended. We are happy to make the request but do not know when we will receive a response. Learn more about Fast-Track Requests here.

    View full details